 Connection
Ahmed Sallam to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications Ahmed Sallam has written about Vascular Endothelial Growth Factor A.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.623 |
|
|
|
-
ElSheikh RH, Chauhan MZ, Sallam AB. Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration. Biomolecules. 2022 11 03; 12(11).
Score: 0.200
-
Chauhan MZ, Rather PA, Samarah SM, Elhusseiny AM, Sallam AB. Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema. Cells. 2022 06 17; 11(12).
Score: 0.194
-
Kilgore DA, Behrens AW, Siddiqui MZ, Chancellor JR, Phillips PH, Uwaydat SH, Vonlanthen MG, Gonzalez-Krellwitz L, Sallam AB. Inflammatory choroiditis and papillitis from Crohn's disease in a child. J AAPOS. 2021 02; 25(1):37-40.
Score: 0.173
-
Buckle M, Lee A, Mohamed Q, Fletcher E, Sallam A, Healy R, Stratton I, Tufail A, Johnston RL. Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom. Eye (Lond). 2015 Mar; 29(3):403-8.
Score: 0.029
-
Keenan TD, Kelly SP, Sallam A, Mohamed Q, Tufail A, Johnston RL. Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK. Br J Ophthalmol. 2013 Sep; 97(9):1168-72.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|